Culanag Jr, Francisco T.
HRN: 23-06-90 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/27/2023
06/03/2023
IV
1.5gms
Q6H
Septicemia Still With Febrile Episodes
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes